A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for Optimisation
Development of a question prompt list for people living with primary biliary cholangitis - A Delphi Study –
Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study
Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid
Quality of life in Dutch patients with primary biliary cholangitis: Discrepancies between patients' perspectives and objective disease parameters
Ursodeoxycholic acid treatment-induced GLOBE score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid
Measurement properties of the PBC-40 and PBC-27: a Dutch validation study
The association between metabolic comorbidities and clinical outcome in patients with primary biliary cholangitis
Prevalence and impact of extrahepatic autoimmune diseases in primary biliary cholangitis
Diabetes mellitus and outcome in primary biliary cholangitis
The population with primary biliary cholangitis is changing over time: milder disease and more metabolic comorbidities
Increasing prevalence of primary biliary cholangitis in The Netherlands
The male-to-female ratio among patients with primary biliary cholangitis depends on age
Factors associated with the real-world biochemical response to fibrate therapy in primary biliary cholangitis
The impact of ursodeoxycholic acid on biochemistry of patients with primary biliary cholangitis in a nationwide cohort
Evaluation of response to UDCA in a nationwide population with primary biliary cholangitis
